United States · FDA National Drug Code directory
Ondansetron Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62135-555_476a94c7-d201-ccb7-e063-6294a90a8cd9
- Product NDC
- 62135-555
- Form
- SOLUTION
- Composition / generic term
- Ondansetron Hydrochloride
- Labeler
- Chartwell RX, LLC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20110127
- Source listing expiry
- 20271231
Source-listed ingredients
- ONDANSETRON HYDROCHLORIDE — 4 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 TRAY in 1 BOX (62135-555-24) / 10 PACKAGE in 1 TRAY / 5 mL in 1 PACKAGE (62135-555-45) · 62135-555-24
- 50 mL in 1 BOTTLE (62135-555-58) · 62135-555-58
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →